Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2000Infection and Immunity

Potentiality of Interleukin-18 as a Useful Reagent for Treatment and Prevention ofLeishmania majorInfection

View Full Paper
Ask AI
Bookmark
Share

Authors

KOKazunobu OhkusuTYTomohiro YoshimotoKTKiyoshi Takeda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ohkusu et al. (2000) studied this question.

synapsesocial.com/papers/6a87fca52053543484aa668ahttps://doi.org/10.1128/iai.68.5.2449-2456.2000
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Adjuvant Effect of Interleukin-12 in a Vaccine Against <i>Leishmania major</i>1994 · 682 citations
  2. 2Administration of monoclonal anti-IFN-<i>gamma</i> antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with <i>Leishmania major</i>.1989 · 371 citations
  3. 3Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution1990 · 84 citations
  4. 4Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling1998 · 329 citations
  5. 5Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes1993 · 1,754 citations